Related Experiment Video
Updated: Aug 31, 2025

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
TPL2 kinase expression is regulated by the p38γ/p38δ-dependent association of aconitase-1 with TPL2 mRNA
Alejandra Escós1, José Martín-Gómez1, Diego González-Romero1
1Department of Immunology and Oncology, Centro Nacional de Biotecnología-Consejo Superior de Investigaciones Científicas (CNB/CSIC) Campus Universidad Autónoma de Madrid (UAM), Madrid, 28049 Spain.
Abstract:
p38γ and p38δ (p38γ/p38δ) regulate inflammation, in part by controlling tumor progression locus 2 (TPL2) expression in myeloid cells. Here, we demonstrate that TPL2 protein levels are dramatically reduced in p38γ/p38δ-deficient (p38γ/δ-/-) cells and tissues without affecting TPL2 messenger ribonucleic acid (mRNA) expression. We show that p38γ/p38δ posttranscriptionally regulates the TPL2 amount at two different levels. p38γ/p38δ interacts with the TPL2/A20 Binding Inhibitor of NF-κB2 (ABIN2)/Nuclear Factor κB1p105 (NF-κB1p105) complex, increasing TPL2 protein stability. Additionally, p38γ/p38δ regulates TPL2 mRNA translation by modulating the repressor function of TPL2 3' Untranslated region (UTR) mediated by its association with aconitase-1 (ACO1). ACO1 overexpression in wild-type cells increases the translational repression induced by TPL2 3'UTR and severely decreases TPL2 protein levels. p38δ binds to ACO1, and p38δ expression in p38γ/δ-/- cells fully restores TPL2 protein to wild-type levels by reducing the translational repression of TPL2 mRNA. This study reveals a unique mechanism of posttranscriptional regulation of TPL2 expression, which given its central role in innate immune response, likely has great relevance in physiopathology.
Insights
p38γ/p38δ kinases regulate inflammation by controlling tumor progression locus 2 (TPL2) protein levels. They enhance TPL2 stability and translation, revealing a novel posttranscriptional regulation mechanism crucial for innate immunity.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- p38γ and p38δ (p38γ/p38δ) kinases are key regulators of inflammation.
- Tumor progression locus 2 (TPL2) is a critical mediator in myeloid cell-driven inflammatory responses.
Purpose of the Study:
- To elucidate the posttranscriptional regulatory mechanisms by which p38γ/p38δ control TPL2 expression.
- To investigate the role of p38γ/p38δ in TPL2 protein stability and mRNA translation.
Main Methods:
- Analysis of TPL2 protein and mRNA levels in p38γ/δ-deficient cells and tissues.
- Co-immunoprecipitation assays to study protein complex formation.
- Assessment of mRNA translation efficiency and protein stability.
- Functional studies involving aconitase-1 (ACO1) manipulation.
Main Results:
- TPL2 protein levels are significantly reduced in p38γ/δ-/- cells, independent of mRNA levels.
- p38γ/p38δ interact with the TPL2/A20 Binding Inhibitor of NF-κB2 (ABIN2)/Nuclear Factor κB1p105 (NF-κB1p105) complex, stabilizing TPL2 protein.
- p38γ/p38δ modulate TPL2 mRNA translation by regulating the repressor activity of the TPL2 3' Untranslated Region (UTR) via aconitase-1 (ACO1).
- p38δ directly binds ACO1, and its reintroduction restores TPL2 protein levels by alleviating translational repression.
Conclusions:
- p38γ/p38δ control TPL2 expression through a dual posttranscriptional mechanism involving protein stabilization and translational control.
- This regulation is mediated by interactions with the TPL2 complex and modulation of ACO1-dependent translational repression.
- The findings reveal a novel regulatory pathway for TPL2, highlighting its significance in innate immunity and potential relevance in physiopathology.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
MAPK Signaling Cascades
Cell Specific Gene Expression
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

